CN107074801B - 芳基和芳基烷基取代的吡唑基和嘧啶基三环烯酮作为抗氧化炎症调节剂 - Google Patents
芳基和芳基烷基取代的吡唑基和嘧啶基三环烯酮作为抗氧化炎症调节剂 Download PDFInfo
- Publication number
- CN107074801B CN107074801B CN201580015069.4A CN201580015069A CN107074801B CN 107074801 B CN107074801 B CN 107074801B CN 201580015069 A CN201580015069 A CN 201580015069A CN 107074801 B CN107074801 B CN 107074801B
- Authority
- CN
- China
- Prior art keywords
- oxo
- phenyl
- carbonitrile
- methyl
- hexahydrobenzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931291P | 2014-01-24 | 2014-01-24 | |
| US61/931291 | 2014-01-24 | ||
| PCT/US2015/012579 WO2015112792A1 (en) | 2014-01-24 | 2015-01-23 | Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107074801A CN107074801A (zh) | 2017-08-18 |
| CN107074801B true CN107074801B (zh) | 2021-11-05 |
Family
ID=52484552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580015069.4A Active CN107074801B (zh) | 2014-01-24 | 2015-01-23 | 芳基和芳基烷基取代的吡唑基和嘧啶基三环烯酮作为抗氧化炎症调节剂 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9464082B2 (OSRAM) |
| EP (1) | EP3097089B1 (OSRAM) |
| JP (1) | JP6530758B2 (OSRAM) |
| CN (1) | CN107074801B (OSRAM) |
| CA (1) | CA2936550C (OSRAM) |
| MX (1) | MX372772B (OSRAM) |
| TW (1) | TWI670263B (OSRAM) |
| WO (1) | WO2015112792A1 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8124799B2 (en) | 2008-04-18 | 2012-02-28 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 |
| KR101665042B1 (ko) | 2008-04-18 | 2016-10-11 | 리타 파마슈티컬스 잉크. | 소염성 골격군을 포함하는 화합물 및 사용 방법 |
| DK2841445T3 (en) | 2012-04-27 | 2017-09-11 | Reata Pharmaceuticals Inc | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONMETHYL, POLYMORPHE FORMS THEREOF AND PROCEDURES FOR USING IT |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| AR096046A1 (es) | 2013-04-24 | 2015-12-02 | Abbvie Inc | Derivados de 2,2-difluoropropanamida de metil bardoxolona, formas polimórficas y métodos de uso |
| NZ734292A (en) * | 2015-02-12 | 2022-09-30 | Reata Pharmaceuticals Inc | Imidazolyl tricyclic enones as antioxidant inflammation modulators |
| KR20190084310A (ko) | 2016-11-23 | 2019-07-16 | 바이엘 크롭사이언스 악티엔게젤샤프트 | 살충제로서의 2-[3-(알킬술포닐)-2H-인다졸-2-일]-3H-이미다조[4,5-b]피리딘 유도체 및 유사한 화합물 |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| JP7498122B2 (ja) * | 2018-06-15 | 2024-06-11 | リアタ ファーマシューティカルズ インコーポレイテッド | ＩＬ－１７およびＲＯＲγの阻害用のピラゾール化合物およびイミダゾール化合物 |
| EP3810141A1 (en) | 2018-06-20 | 2021-04-28 | Reata Pharmaceuticals, Inc. | Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith |
| WO2023092034A1 (en) * | 2021-11-17 | 2023-05-25 | Northwestern University | Wt-idh1 inhibition using a covalent and brain-penetrant small molecular inhibitor for ferroptosis induction in high-grade glioma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012083306A2 (en) * | 2010-12-17 | 2012-06-21 | Reata Pharmaceuticals, Inc. | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1142889A1 (en) * | 2000-04-03 | 2001-10-10 | Pfizer Products Inc. | Pyrazole derivatives as anti-inflammatory/analgesic agents |
| BR0212661A (pt) * | 2001-09-19 | 2004-08-24 | Pharmacia Corp | Compostos de pirazolil benzenossulfamida substituìdos para o tratamento de inflamação |
| AU2011240690C1 (en) | 2010-04-12 | 2014-11-06 | Reata Pharmaceuticals Holdings, LLC | Method of treating obesity using antioxidant inflammation modulators |
-
2015
- 2015-01-23 CA CA2936550A patent/CA2936550C/en active Active
- 2015-01-23 MX MX2016009589A patent/MX372772B/es active IP Right Grant
- 2015-01-23 JP JP2016548158A patent/JP6530758B2/ja active Active
- 2015-01-23 CN CN201580015069.4A patent/CN107074801B/zh active Active
- 2015-01-23 WO PCT/US2015/012579 patent/WO2015112792A1/en not_active Ceased
- 2015-01-23 TW TW104102426A patent/TWI670263B/zh active
- 2015-01-23 US US14/604,129 patent/US9464082B2/en active Active
- 2015-01-23 EP EP15705409.9A patent/EP3097089B1/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012083306A2 (en) * | 2010-12-17 | 2012-06-21 | Reata Pharmaceuticals, Inc. | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
Also Published As
| Publication number | Publication date |
|---|---|
| US20150225397A1 (en) | 2015-08-13 |
| JP2017503840A (ja) | 2017-02-02 |
| CN107074801A (zh) | 2017-08-18 |
| WO2015112792A1 (en) | 2015-07-30 |
| JP6530758B2 (ja) | 2019-06-12 |
| MX2016009589A (es) | 2016-10-28 |
| TWI670263B (zh) | 2019-09-01 |
| TW201605808A (zh) | 2016-02-16 |
| CA2936550C (en) | 2022-07-26 |
| CA2936550A1 (en) | 2015-07-30 |
| US9464082B2 (en) | 2016-10-11 |
| EP3097089B1 (en) | 2021-02-24 |
| MX372772B (es) | 2020-06-29 |
| EP3097089A1 (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107074801B (zh) | 芳基和芳基烷基取代的吡唑基和嘧啶基三环烯酮作为抗氧化炎症调节剂 | |
| JP6914257B2 (ja) | Ｒｏｒ−ガンマのモジュレーター | |
| EP2892910B1 (en) | Glycyrrhetinic acid derivatives with anti-inflammatory activity | |
| CA2877550C (en) | Imidazopyridine derivatives as modulators of tnf activity | |
| RU2686117C1 (ru) | Конденсированные производные имидазола и пиразола в качестве модуляторов активности tnf | |
| CA2663401C (en) | Pyrido (2, 3-d) pyrimidinone compounds and their use as pi3 inhibitors | |
| US7868024B2 (en) | Derivatives of N-(heteroaryl)-1-heteroaryl-1H-indole-2-carboxamides, preparation thereof and therapeutic use thereof | |
| JP7200120B2 (ja) | Ｍｋ２阻害剤として有用なヘテロアリール化合物 | |
| EP3436456B1 (en) | Fused hexacyclic imidazole derivatives as modulators of tnf activity | |
| EP3386504A2 (en) | Therapeutic inhibitory compounds | |
| AU2003270783A1 (en) | Octahydro-2-H-naphtho[1,2-F] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators | |
| AU2008226457A1 (en) | Aminopyrimidines useful as inhibitors of protein kinases | |
| WO2009026241A1 (en) | Heterocyclic modulators of tgr5 | |
| AU2004325725A1 (en) | Fused bicycloheterocycle substituted quinuclidine derivatives | |
| EP3596085A1 (en) | Deuterated analogs of mk2 inhibitors and uses thereof | |
| JP2023510622A (ja) | アザビシクロ置換オキサスピロ環誘導体、その調製方法及び医学的使用 | |
| WO2017156177A1 (en) | 3-phosphoglycerate dehydrogenase inhibitors and uses thereof | |
| WO2023072026A1 (en) | Sarm1 modulators, preparations, and uses thereof | |
| EP4634156A1 (en) | Sarm1 modulators, preparations, and uses thereof | |
| HK40055299A (en) | Modulators of ror-gamma | |
| NZ548231A (en) | Fused bicycloheterocycle substituted quinuclidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |